Influence of putative antiinvasive agents on matrix metalloproteinase secretion by human neoplastic glia in vitro.
Rooprai
H K
HK
Department of Neuropathology, Institute of Psychiatry, London, UK. spkahkr@iop.kcl.ac.uk
Kandanearatachi
A
A
Rucklidge
G
G
Pilkington
G J
GJ
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001932:Brain Neoplasms / Q000201:enzymology* / Q000473:pathology; D002216:Captopril / Q000494:pharmacology; D017364:Collagenases / Q000096:biosynthesis; D047309:Flavones; D005419:Flavonoids / Q000494:pharmacology; D018093:Gelatinases / Q000096:biosynthesis; D005910:Glioma / Q000201:enzymology* / Q000473:pathology; D006801:Humans; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D009361:Neoplasm Invasiveness / Q000517:prevention & control*; D017026:Swainsonine / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D047309:Flavones; D005419:Flavonoids; D002216:Captopril; C008661:nobiletin; D017364:Collagenases; D018093:Gelatinases; D008666:Metalloendopeptidases; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9; C059006:tangeretin; D017026:Swainsonine